Literature DB >> 20064924

Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA.

Ernest Blackwell1, Xing Zhang, Stephanie Ceman.   

Abstract

Fragile X syndrome is caused by the loss of expression of the fragile X mental retardation protein, FMRP. FMRP is an RNA-binding protein that is highly expressed in neurons and undergoes multiple post-translational modifications including methylation on arginine. FMRP is methylated on the high-affinity RNA-binding motif, the RGG box, at positions 533, 538, 543 and 545 of murine FMRP. To identify the arginines important for FMRP function, we examined their role in polyribosome and mRNA association. We found that arginines 533 and 538 were required for normal FMRP polyribosome association whereas all four arginines played a role in RNA binding, depending on the identity of the RNA. The model G-quadruplex RNA sc1 required arginines 533 and 538 for normal association with FMRP, whereas AATYK mRNA did not. In vitro methylation of FMRP-bearing arginine substitutions inhibited sc1 binding but not AATYK binding. In addition, we found that PRMT1 co-immunoprecipitated with FMRP isolated from cells and that siRNAs directed against PRMT1 led to reduced FMRP methylation. Thus, two lines of experimentation demonstrate that PRMT1 acts on FMRP in cells. In summary, we provide evidence for the important role of the RGG box in polyribosome association. We also demonstrate for the first time that the different arginines of the RGG box are important for the binding of different RNAs. Finally, we show that PRMT1 methylates FMRP in cells, suggesting a model where methylation of the RGG box modulates either the quantity or the identity of the RNAs bound by FMRP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064924      PMCID: PMC2838539          DOI: 10.1093/hmg/ddq007

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  54 in total

1.  Protein-RNA interactions: a structural analysis.

Authors:  S Jones; D T Daley; N M Luscombe; H M Berman; J M Thornton
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

2.  Evidence that fragile X mental retardation protein is a negative regulator of translation.

Authors:  B Laggerbauer; D Ostareck; E M Keidel; A Ostareck-Lederer; U Fischer
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

Review 3.  State of the arg: protein methylation at arginine comes of age.

Authors:  A E McBride; P A Silver
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

4.  The fragile X mental retardation protein inhibits translation via interacting with mRNA.

Authors:  Z Li; Y Zhang; L Ku; K D Wilkinson; S T Warren; Y Feng
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

5.  Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex.

Authors:  S Ceman; V Brown; S T Warren
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Statistical analysis of atomic contacts at RNA-protein interfaces.

Authors:  M Treger; E Westhof
Journal:  J Mol Recognit       Date:  2001 Jul-Aug       Impact factor: 2.137

7.  Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable.

Authors:  M R Pawlak; C A Scherer; J Chen; M J Roshon; H E Ruley
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

8.  The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.

Authors:  C Schaeffer; B Bardoni; J L Mandel; B Ehresmann; C Ehresmann; H Moine
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

9.  Fragile X mental retardation protein recognition of G quadruplex structure per se is sufficient for high affinity binding to RNA.

Authors:  Medhavi Bole; Lakshmi Menon; Mihaela-Rita Mihailescu
Journal:  Mol Biosyst       Date:  2008-10-27

10.  Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively.

Authors:  Knut Kölbel; Christian Ihling; Kathrin Bellmann-Sickert; Ines Neundorf; Annette G Beck-Sickinger; Andrea Sinz; Uwe Kühn; Elmar Wahle
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

View more
  50 in total

1.  Translational repression of the disintegrin and metalloprotease ADAM10 by a stable G-quadruplex secondary structure in its 5'-untranslated region.

Authors:  Sven Lammich; Frits Kamp; Judith Wagner; Brigitte Nuscher; Sonja Zilow; Ann-Katrin Ludwig; Michael Willem; Christian Haass
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

2.  PRMT1 methylates the single Argonaute of Toxoplasma gondii and is important for the recruitment of Tudor nuclease for target RNA cleavage by antisense guide RNA.

Authors:  Alla Musiyenko; Tanmay Majumdar; Joel Andrews; Brian Adams; Sailen Barik
Journal:  Cell Microbiol       Date:  2012-02-28       Impact factor: 3.715

3.  PRMT1-p53 Pathway Controls Epicardial EMT and Invasion.

Authors:  Olan Jackson-Weaver; Nicha Ungvijanpunya; Yuan Yuan; Jiang Qian; Yongchao Gou; Jian Wu; Hua Shen; Yibu Chen; Meng Li; Stéphane Richard; Yang Chai; Henry M Sucov; Jian Xu
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

Review 4.  Protein arginine methylation in parasitic protozoa.

Authors:  John C Fisk; Laurie K Read
Journal:  Eukaryot Cell       Date:  2011-06-17

5.  Kinase pathway inhibition restores PSD95 induction in neurons lacking fragile X mental retardation protein.

Authors:  Ying Yang; Yang Geng; Dongyun Jiang; Lin Ning; Hyung Joon Kim; Noo Li Jeon; Anthony Lau; Lu Chen; Michael Z Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

6.  Dysregulation of RBFOX2 Is an Early Event in Cardiac Pathogenesis of Diabetes.

Authors:  Curtis A Nutter; Elizabeth A Jaworski; Sunil K Verma; Vaibhav Deshmukh; Qiongling Wang; Olga B Botvinnik; Mario J Lozano; Ismail J Abass; Talha Ijaz; Allan R Brasier; Nisha J Garg; Xander H T Wehrens; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  Cell Rep       Date:  2016-05-26       Impact factor: 9.423

Review 7.  Protein phase separation: A novel therapy for cancer?

Authors:  Wei Wang; Yingqian Chen; Aixiao Xu; Minyi Cai; Ji Cao; Hong Zhu; Bo Yang; Xuejing Shao; Meidan Ying; Qiaojun He
Journal:  Br J Pharmacol       Date:  2020-09-28       Impact factor: 8.739

Review 8.  Arginine methylation of RNA-binding proteins regulates cell function and differentiation.

Authors:  Ernest Blackwell; Stephanie Ceman
Journal:  Mol Reprod Dev       Date:  2012-01-23       Impact factor: 2.609

9.  A new regulatory function of the region proximal to the RGG box in the fragile X mental retardation protein.

Authors:  Ernest Blackwell; Stephanie Ceman
Journal:  J Cell Sci       Date:  2011-08-24       Impact factor: 5.285

Review 10.  RNA-binding proteins in eye development and disease: implication of conserved RNA granule components.

Authors:  Soma Dash; Archana D Siddam; Carrie E Barnum; Sarath Chandra Janga; Salil A Lachke
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-01       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.